AST-to-Platelet Ratio Index Calculator
Calculate APRI from AST, laboratory AST ULN, and platelet count.
Content updated: View sources
AST-to-Platelet Ratio Index
—
Noninvasive laboratory index; no fibrosis category is assigned
AST/ULN: — · platelets: — ×10⁹/L
About
The AST-to-Platelet Ratio Index (APRI) is a noninvasive index originally developed in treatment-naive adults with chronic hepatitis C. This page reports the arithmetic without assigning a fibrosis stage.
Formula
Interpretation
What the result represents: AST relative to the reporting laboratory upper limit, scaled by platelet count.
Input units: AST and its laboratory ULN use U/L. Platelets may use ×10³/µL, ×10⁹/L, or cells/µL and are normalized to ×10⁹/L.
Worked example: AST 80 U/L, AST ULN 40 U/L, and platelets 200 ×10⁹/L gives APRI 1.00.
Applicable population: Originally derived for chronic hepatitis C; performance and cutoffs differ by liver disease, population, and clinical purpose.
Interpretation limitations: APRI does not by itself diagnose or exclude fibrosis or cirrhosis. AST from nonhepatic causes and platelet changes from other conditions affect the index. Interpret with clinical context, other noninvasive assessment, imaging, and specialist evaluation where appropriate.
FAQ
Disclaimer
Educational and informational reference only. Not intended to replace professional medical advice, diagnosis, treatment, or independent verification.